Hainan Haiyao Co Ltd (SHE:000566) — Market Cap & Net Worth
Market Cap & Net Worth: Hainan Haiyao Co Ltd (000566)
Hainan Haiyao Co Ltd (SHE:000566) has a market capitalization of $715.72 Million (CN¥4.89 Billion) as of June 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #10614 globally and #2937 in its home market, demonstrating a -2.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hainan Haiyao Co Ltd's stock price CN¥3.77 by its total outstanding shares 1297365126 (1.30 Billion). Review total liabilities of Hainan Haiyao Co Ltd to assess the company's total debt and financial obligations.
Hainan Haiyao Co Ltd Market Cap History: 2015 to 2026
Hainan Haiyao Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $3.59 Billion to $715.72 Million (-16.04% CAGR).
Hainan Haiyao Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hainan Haiyao Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.92x
Hainan Haiyao Co Ltd's market cap is 0.92 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.59 Billion | $1.64 Billion | $195.27 Million | 2.19x | 18.41x |
| 2016 | $2.35 Billion | $1.51 Billion | $164.63 Million | 1.56x | 14.28x |
| 2017 | $2.41 Billion | $1.82 Billion | $86.63 Million | 1.32x | 27.84x |
| 2018 | $972.01 Million | $2.47 Billion | $119.57 Million | 0.39x | 8.13x |
| 2019 | $1.14 Billion | $2.45 Billion | -$159.13 Million | 0.46x | N/A |
| 2020 | $1.75 Billion | $2.20 Billion | -$580.21 Million | 0.80x | N/A |
| 2021 | $996.69 Million | $2.06 Billion | -$1.56 Billion | 0.48x | N/A |
| 2022 | $810.64 Million | $1.78 Billion | $10.51 Million | 0.46x | 77.15x |
| 2023 | $858.10 Million | $1.48 Billion | -$106.49 Million | 0.58x | N/A |
| 2024 | $909.36 Million | $990.70 Million | -$1.53 Billion | 0.92x | N/A |
Competitor Companies of 000566 by Market Capitalization
Companies near Hainan Haiyao Co Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Hainan Haiyao Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #555 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #601 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Hainan Haiyao Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Hainan Haiyao Co Ltd's market cap moved from $3.59 Billion to $ 715.72 Million, with a yearly change of -16.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥715.72 Million | -47.27% |
| 2025 | CN¥1.36 Billion | +49.27% |
| 2024 | CN¥909.36 Million | +5.97% |
| 2023 | CN¥858.10 Million | +5.85% |
| 2022 | CN¥810.64 Million | -18.67% |
| 2021 | CN¥996.69 Million | -43.12% |
| 2020 | CN¥1.75 Billion | +54.35% |
| 2019 | CN¥1.14 Billion | +16.80% |
| 2018 | CN¥972.01 Million | -59.70% |
| 2017 | CN¥2.41 Billion | +2.57% |
| 2016 | CN¥2.35 Billion | -34.59% |
| 2015 | CN¥3.59 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Hainan Haiyao Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $715.72 Million USD |
| MoneyControl | $715.72 Million USD |
| MarketWatch | $715.72 Million USD |
| marketcap.company | $715.72 Million USD |
| Reuters | $715.72 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hainan Haiyao Co Ltd
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers intermediates, active pharmaceutical ingredients (APIs), innovative chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, cell immunotherapy, and medical devices, as well as big health category products, digestive and anti-infective product… Read more